Literature DB >> 30033375

Access to opioid agonist therapy in Russia: time for reform.

Alexei Zelenev1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30033375      PMCID： PMC7122734          DOI： 10.1016/S2352-3018(18)30170-X

Source DB:  PubMed          Journal:  Lancet HIV        ISSN： 2352-3018            Impact factor:   12.767


× No keyword cloud information.
  7 in total

1.  Russia's drug policy fuels infectious disease epidemics.

Authors:  Talha Burki
Journal:  Lancet Infect Dis       Date:  2012-04       Impact factor: 25.071

Review 2.  The Policy-Driven HIV Epidemic Among Opioid Users in the Russian Federation.

Authors:  Robert Heimer
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

Review 3.  Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

Authors:  Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

Review 4.  Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Authors:  M Connock; A Juarez-Garcia; S Jowett; E Frew; Z Liu; R J Taylor; A Fry-Smith; E Day; N Lintzeris; T Roberts; A Burls; R S Taylor
Journal:  Health Technol Assess       Date:  2007-03       Impact factor: 4.014

5.  Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Ruthanne Marcus; Iryna Pykalo; Lynn Madden; Sergii Filippovich; Sergii Dvoriak; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2018-01-11

6.  Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.

Authors:  Alexei Zelenev; Portia Shea; Alyona Mazhnaya; Julia Rozanova; Lynn Madden; Ruthanne Marcus; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2018-06-30       Impact factor: 4.492

7.  Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.

Authors:  Javier A Cepeda; Ksenia Eritsyan; Peter Vickerman; Alexandra Lyubimova; Marina Shegay; Veronika Odinokova; Leo Beletsky; Annick Borquez; Matthew Hickman; Chris Beyrer; Natasha K Martin
Journal:  Lancet HIV       Date:  2018-07-20       Impact factor: 12.767
  7 in total
  3 in total

1.  Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia-A prospective cohort analysis.

Authors:  Marina Vetrova; Sara Lodi; Lindsey Rateau; Gregory Patts; Elena Blokhina; Vladimir Palatkin; Tatiana Yaroslavtseva; Olga Toussova; Natalia Bushara; Sally Bendiks; Natalia Gnatienko; Evgeny Krupitsky; Dmitry Lioznov; Jeffrey H Samet; Karsten Lunze
Journal:  Int J Drug Policy       Date:  2022-02-05

2.  Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis.

Authors:  Anh T Vo; Christopher Magana; Matthew Hickman; Annick Borquez; Leo Beletsky; Natasha K Martin; Javier A Cepeda
Journal:  Int J Drug Policy       Date:  2021-08-11

3.  Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.

Authors: 
Journal:  Lancet HIV       Date:  2019-08-19       Impact factor: 16.070
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.